French National Observatory of the Patients With Non-small Cell Lung (NSCLC) and Molecular Testings

Plain-language summary

This is a national observational study that follows people with advanced non-small cell lung cancer (NSCLC) and the molecular (genetic) tests performed for them. It enrolled patients with advanced NSCLC who had biomarker analysis done on hospital platforms. It was carried out as an observational study without an assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Intergroupe Francophone de Cancerologie Thoracique

Start date

4/1/2012

Estimated completion

4/1/2013

Countries

France

Related genes

Locations

• Agen, France
• Albi, France
• Amiens, France
• Angers, France
• Antony, France
• Aulnay-sous-Bois, France
• Auxerre, France
• Avignon, France
• Bayonne, France
• Besançon, France
• Béziers, France
• Blois, France
• Bobigny, France
• Boulogne, France
• Bourg-en-Bresse, France
• Briançon, France
• Caen, France
• Cahors, France
• Cannes, France
• Chambray-lès-Tours, France
• Chartres, France
• Chevilly-Larue, France
• Cholet, France
• Clamart, France
• Colmar, France
• Cornebarrieu, France
• Créteil, France
• Dax, France
• Denain, France
• Dijon, France
• Dijon, France
• Draguignan, France
• Dreux, France
• Elbeuf, France
• Ermont, France
• Épinal, France
• Évreux, France
• Flers, France
• Gap, France
• Grenoble, France

+93

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Advanced Non-small cell lung cancer (NSLC)
* Biomarkers analysis on hospital platforms

Exclusion Criteria:

\- Histology other than NSLC